DURHAM, NC, and LIEGE, BELGIUM - May 3, 2010, 8:00 CET - OncoMethylome Sciences(Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading moleculardiagnostics company, presented an update on its blood-based colorectal screeningtest and promising preliminary results of the performance of its proprietary DNAmethylation biomarker in combination with stool-based testing at the AnnualDigestive Disease Week (DDW) Conference. The presentation was part of anoverview of the company's colorectal cancer screening program given at the WorldOrganization of Digestive Endoscopy (OMED) Colorectal Cancer Screening CommitteeMeeting,
More...
More...